Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks (SUNHA): results from an open-label phase Ib ascending dose study (, September 2024)
Links to other websites do not imply affiliation or endorsement. 51³Ô¹ÏÍø does not control and is not responsible for their content.
